Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Clasificación en acciones #27702
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Precio por acción
$2.18
Capitalización bursátil
$31.27M
Cambio (1 día)
2.27%
Cambio (1 año)
-61.30%
País
KR
Comercio IMBdx (461030)

Categoría

Ratio P/S de IMBdx (461030)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de IMBdx, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de IMBdx desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH